Smith Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
Smith Asset Management's BME Position: Q3 2026 in Review
Smith Asset Management reduced its BlackRock Health Sciences Trust (BME) stake by 5.5% in Q3 2026, selling an estimated $39.5K and leaving 15,287 shares worth $675K. The position accounts for 0.55% of the portfolio, ranked #46.
Smith Asset Management first reported a position in BME in Q1 2025 and has held it in 7 quarters since. The position peaked at $695K in Q2 2026. 23 funds tracked by Wall St. Rank hold BME as of Q3 2026.
- Smith Asset Management held 15,287 shares of BlackRock Health Sciences Trust worth $675K as of Q3 2026.
- Smith Asset Management sold 892 BlackRock Health Sciences Trust shares in Q3 2026, an estimated $39.5K.
- BlackRock Health Sciences Trust made up 0.55% of Smith Asset Management's portfolio in Q3 2026, its #46 holding.
- Smith Asset Management first reported a position in BlackRock Health Sciences Trust in Q1 2025 and has held it in 7 quarters since.
- Smith Asset Management's BlackRock Health Sciences Trust position peaked at $695K in Q2 2026.
- 23 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2026.
Based on Smith Asset Management's 13F filing for Q3 2026, filed 16 Oct 2026.